Severe Deterioration of Metabolic Control Caused by Malfunction of a Disposable Insulin Pen Device

References

1. ↵
   Thurman JE. Insulin pen injection devices for management of patients with type 2 diabetes: considerations based on an endocrinologist's practical experience in the United States. Endocr Pract 2007; 13: 672–8.

   OpenUrlPubMed
2. ↵
   Brown A, Steel JM, Duncan C, Duncan A, McBain AM. An assessment of the adequacy of suspension of insulin in pen injectors. Diabet Med 2004; 21: 604–8.

   OpenUrlCrossRefPubMed
3. ↵
   Strauss K, De Gols H, Hannet I, Partanen TM, Frid A. A pan-European epidemiologic study of insulin injection technique in patients with diabetes. Practical Diabetes Int 2002; 19: 71–6.

   OpenUrl
4. ↵
   Albareda M, Balmes L, Wagner A, Corcoy R. Insulin pens and acute deterioration in blood glucose control. Arch Intern Med 1999; 159: 100.

   OpenUrlPubMed
5. Patel S, Crowley S. My pen ran cold (Horace Walpole). Practical Diabetes Int 1990; 7: 16.

   OpenUrl
6. Goksen D, Darcan S, Buyukinan M, Kurt E. Possible problem with Optipen Pro-1: should diabetic patients continue to use this product?. Diabetes Care 2006; 29: 1710–1.

   OpenUrlFREE Full Text
7. ↵
   Bhardwaj VR, Metcalfe N, Innes E, Harrison E, Jenkins D. Recurrent diabetic ketoacidosis after changing pen devices for insulin injection. BMJ 2006; 332: 1259–60.

   OpenUrlFREE Full Text